# Patterns of Prescribing and Monitoring of Palbociclib

> **NCT03285568** · — · COMPLETED · sponsor: **Rush University Medical Center** · enrollment: 67 (actual)

## Conditions studied

- Metastatic Breast Cancer
- Advanced Breast Cancer
- Estrogen Receptor-positive Breast Cancer
- Human Epidermal Growth Factor 2 Negative Carcinoma of Breast

## Interventions

- **DRUG:** Palbociclib

## Key facts

- **NCT ID:** NCT03285568
- **Lead sponsor:** Rush University Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02-03
- **Primary completion:** 2016-12-30
- **Final completion:** 2016-12-30
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2023-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03285568

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03285568, "Patterns of Prescribing and Monitoring of Palbociclib". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03285568. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*